Lida Garros

Publications

• Research Article   
  Efficacy of adjunct therapy with citalopram to improve health-related quality of life and associated symptoms in patients with endometriosis: A randomized clinical trial
  Author(s): Rayhaneh Hosseini, Samira Mirzaei*, Zahra Asgari*, Nasrin Hajiloo and Lida Garros
  
  Aims and Objectives: Given the impact of SSRIs on chronic pain and inflammation in endometriosis pathogenesis, the hypothesis is that incorporating an SSRI drug into the treatment of women with endometriosis may result in a reduction in inflammation and pain. This study aimed to integrate Citalopram into the treatment of endometriosis patients to assess the effects of these medications on endometriosis symptoms and overall health-related quality of life. Materials and Methods: The first group received a dose of citalopram (20 mg to 40 mg) alongside Verogest 2 mg daily for three months. The placebo group received only a daily dosage of 2 mg Verogest. Medications were administered for 12 weeks. Pelvic pain, dysmenorrhea, and dyspareunia, were assessed using a visual pain ruler and the ENDOPAIN-4D questionnaire before and after the intervention. Additionally, participants compl.. Read More»
  

  Abstract HTML PDF